Exact Mass: 733.3161

beta-Phenylalanoyl baccatin III

C40H47NO12 (733.3098)

A taxane diterpenoid that is 3-N-debenzoyltaxol which is lacking the 2-hydroxy group.

Liaconitine B

C41H51NO11 (733.3462)

Dihydrocyclotheonamide A

C36H47N9O8 (733.3547)

Maytanvaline

C37H52ClN3O10 (733.3341)

C36H51N3O13

C36H51N3O13 (733.3422)

3beta-O-propionyl-5alpha-O-benzoyl-7beta,13beta-di-O-acetyl-17-O-nicotinoylpremyrsinol|euphorbialoid C

C40H47NO12 (733.3098)

atkamine

C40H52BrN3O3S (733.2913)

p53 and MDM2 proteins-interaction-inhibitor (racemic)

C40H49Cl2N5O4 (733.3161)

p53 and MDM2 proteins-interaction-inhibitor chiral

C40H49Cl2N5O4 (733.3161)

p53 and MDM2 proteins-interaction-inhibitor (chiral) (Compound 32) is an inhibitor of the interaction between p53 and MDM2 proteins.

N-Debenzoyl-2-deoxytaxol

C40H47NO12 (733.3098)

(beta-D-glucosyl)-(1->4)-(2-O-methyl-beta-D-glucosyl)-(1->4)-(beta-D-glucosyl)-O-mycofactocinone

C32H47NO18 (733.2793)

Cyclodepsipeptide 2

C36H51N3O13 (733.3422)

An 18-membered cyclodepsipeptide having a 3-formamido-2-hydroxybenzoyl group attached to the amino terminus. It is isolated from an Alaskan Kitasatospora sp. and exhibits antineoplastic activity.

3-N-Debenzoyl-2-deoxytaxol

C40H47NO12 (733.3098)

N-(2-hydroxyethyl)-2-[(2R,3R,3S,4R)-3-[(4-methoxyphenyl)-dimethylsilyl]-4-methyl-2-oxo-1-[[4-(2-oxo-3-oxazolidinyl)phenyl]methyl]-2-spiro[indole-3,5-oxolane]yl]-N-(phenylmethyl)acetamide

C42H47N3O7Si (733.3183)

(2R,4S,5R,6R)-2-[(2R,3S,4R,5S)-5-Acetamido-4-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,6-trihydroxyhexoxy]-4-hydroxy-5-[(2-hydroxyacetyl)amino]-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid

C27H47N3O20 (733.2753)

(2R,4S,5R,6R)-2-[(2R,3S,4R,5S)-5-Acetamido-4-[(2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,6-trihydroxyhexoxy]-4-hydroxy-5-[(2-hydroxyacetyl)amino]-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid

C27H47N3O20 (733.2753)

(2R,4S,5R,6R)-2-[(2R,3S,4R,5S)-5-Acetamido-4-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,6-trihydroxyhexoxy]-4-hydroxy-5-[(2-hydroxyacetyl)amino]-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid

C27H47N3O20 (733.2753)

5-aminopentyl (alpha-D-glucopyranosyluronic acid)-(1->6)-alpha-D-glucopyranosyl-(1->2)-alpha-L-rhamnopyranosyl-(1->3)-alpha-L-rhamnopyranoside

C29H51NO20 (733.3004)

[(1S,2S,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(3R)-3-amino-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate

C40H47NO12 (733.3098)

LNAPS 32:9;O

C38H56NO11P (733.3591)

PS 22:6/9:4;O2

C37H52NO12P (733.3227)

PS 31:10;O2

C37H52NO12P (733.3227)

Norbinaltorphimine dihydrochloride

C40H45Cl2N3O6 (733.2685)

Norbinaltorphimine dihydrochloride is a potent and selective κ opioid receptor antagonist.

3'-n-debenzoyl-2'-deoxytaxol

C40H47NO12 (733.3098)

2-hydroxy-n-[6-hydroxy-13-isopropyl-2,10,10,16-tetramethyl-8-(2-methylpropyl)-3,9,11,14,18-pentaoxo-5-(sec-butyl)-1,4,12,15-tetraoxa-7-azacyclooctadec-6-en-17-yl]-3-[(hydroxymethylidene)amino]benzenecarboximidic acid

C36H51N3O13 (733.3422)

(1s,2r,5s,6s,16e,18e,20r,21s)-11-chloro-21,23-dihydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8-oxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1¹⁰,¹⁴.0³,⁵]hexacosa-10,12,14(26),16,18,22-hexaen-6-yl (2s)-2-(n,3-dimethylbutanamido)propanoate

C37H52ClN3O10 (733.3341)

n-[7-benzyl-3-(3-carbamimidamidopropyl)-1,4,5,8,13-pentahydroxy-10-[(4-hydroxyphenyl)methyl]-17-oxo-3h,4h,7h,10h,15h,16h,19h,20h,21h,21ah-pyrrolo[2,1-j]1,4,8,11,15-pentaazacyclononadecan-16-yl]carboximidic acid

C36H47N9O8 (733.3547)

(1s,2r,3s,5s,16z,18z,20r,21s)-11-chloro-21,23-dihydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8-oxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1¹⁰,¹⁴.0³,⁵]hexacosa-10,12,14(26),16,18,22-hexaen-6-yl (2s)-2-(n,3-dimethylbutanamido)propanoate

C37H52ClN3O10 (733.3341)

11-ethyl-5-hydroxy-6,16,18-trimethoxy-4-(4-methoxybenzoyloxy)-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-14-en-8-yl 4-methoxybenzoate

C41H51NO11 (733.3462)

[(1r,2r,3r,4s,5s,7r,9s,10r,11s,13s,15r)-9,15-bis(acetyloxy)-2-(benzoyloxy)-7-hydroxy-5,9,12,12-tetramethyl-8-oxo-4-(propanoyloxy)tetracyclo[8.5.0.0³,⁷.0¹¹,¹³]pentadecan-1-yl]methyl pyridine-3-carboxylate

C40H47NO12 (733.3098)

(1s,2r,3r,4r,5s,6s,8r,9r,10r,13s,16s,17r,18r)-11-ethyl-5-hydroxy-6,16,18-trimethoxy-4-(4-methoxybenzoyloxy)-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-14-en-8-yl 4-methoxybenzoate

C41H51NO11 (733.3462)

(1s,2r,3r,4r,5s,6s,8s,9r,10r,16s,17r,18s)-11-ethyl-5-hydroxy-6,16,18-trimethoxy-4-(4-methoxybenzoyloxy)-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-14-en-8-yl 4-methoxybenzoate

C41H51NO11 (733.3462)

n-[(3s,4r,7r,10s,16s,21as)-7-benzyl-3-(3-carbamimidamidopropyl)-1,4,5,8,13-pentahydroxy-10-[(4-hydroxyphenyl)methyl]-17-oxo-3h,4h,7h,10h,15h,16h,19h,20h,21h,21ah-pyrrolo[2,1-j]1,4,8,11,15-pentaazacyclononadecan-16-yl]carboximidic acid

C36H47N9O8 (733.3547)

(5s,6s,8r)-11-ethyl-5-hydroxy-6,16,18-trimethoxy-8-(4-methoxybenzoyloxy)-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-14-en-4-yl 4-methoxybenzoate

C41H51NO11 (733.3462)

2-hydroxy-n-[(2s,5s,8s,13s,16r,17s)-6-hydroxy-13-isopropyl-2,10,10,16-tetramethyl-8-(2-methylpropyl)-3,9,11,14,18-pentaoxo-5-(sec-butyl)-1,4,12,15-tetraoxa-7-azacyclooctadec-6-en-17-yl]-3-[(hydroxymethylidene)amino]benzenecarboximidic acid

C36H51N3O13 (733.3422)

(1s,2r,3r,4r,5s,6s,8s,9r,10r,13r,16s,17r,18s)-11-ethyl-5-hydroxy-6,16,18-trimethoxy-4-(4-methoxybenzoyloxy)-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-14-en-8-yl 4-methoxybenzoate

C41H51NO11 (733.3462)